|
1
|
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.
|
Nat Med
|
2011
|
3.60
|
|
2
|
Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells.
|
PLoS Pathog
|
2007
|
2.36
|
|
3
|
Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria.
|
Mol Microbiol
|
2008
|
2.35
|
|
4
|
Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
|
Vaccine
|
2006
|
1.97
|
|
5
|
Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates.
|
Vaccine
|
2009
|
1.38
|
|
6
|
Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production.
|
PLoS Pathog
|
2008
|
1.30
|
|
7
|
Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.
|
J Virol
|
2006
|
1.22
|
|
8
|
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves.
|
Vaccine
|
2009
|
1.22
|
|
9
|
Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells.
|
Mol Microbiol
|
2009
|
1.09
|
|
10
|
Use of a Mycoplasma hyopneumoniae nested polymerase chain reaction test to determine the optimal sampling sites in swine.
|
J Vet Diagn Invest
|
2002
|
1.00
|
|
11
|
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.
|
Clin Vaccine Immunol
|
2006
|
0.99
|
|
12
|
Sulfite reduction in mycobacteria.
|
J Bacteriol
|
2007
|
0.96
|
|
13
|
Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma.
|
Immunology
|
2006
|
0.95
|
|
14
|
Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine.
|
Immunology
|
2006
|
0.92
|
|
15
|
Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.
|
Vaccine
|
2009
|
0.85
|
|
16
|
Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior.
|
J Thorac Oncol
|
2013
|
0.79
|
|
17
|
Einstein Contained Aerosol Pulmonizer (ECAP): Improved Biosafety for Multi-Drug Resistant (MDR) and Extensively Drug Resistant (XDR) Mycobacterium tuberculosis Aerosol Infection Studies.
|
Appl Biosaf
|
2011
|
0.75
|